Editas Medicine (NASDAQ:EDIT)

Therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Editas Medicine (NASDAQ:EDIT) plus 5959 other startups.

Learn More About Editas Medicine (NASDAQ:EDIT)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More